[Clinicopathological and biological features of breast cancer in young females and their relationship with prognosis]
- PMID: 17760256
[Clinicopathological and biological features of breast cancer in young females and their relationship with prognosis]
Abstract
Objective: To study the relationship between clinicopathological and biological characteristics and prognosis in young females with breast cancer.
Methods: The clinicopathological data of 99 young patients (< or =35years) with primary breast cancer were analyzed retrospectively. All the 99 patients were followed up for 5 years. The histological specimens were reviewed. The expression of ER, PR, AR, c-erbB2, ki67, p53 and BRCA1 were assessed by immunohistochemistry in 63 carcinomas.
Results: The lymph node involvement, 5-year metastasis and 5-year survival rate were 59.6% (59/99), 28.0% (26/ 93) and 72.7% (72/99), respectively. The univariate analysis showed that the survival was related to lymphatic vessel invasion, fat involvement, node-positive status, EIC, AR and c-erbB2 expression. The COX multivariate analysis identified that only node-positive status, AR negativity and c-erbB2 overexpression were independent prognostic factors.
Conclusion: Our data demonstrated that the lymph node status and c-erbB2 expression are strong prognostic factors in young patients with breast cancer. AR may be an adjuvant prognostic factor. The therapeutic measurement could not benefit the outcome radically.
Similar articles
-
[Clinical characteristics and prognosis of breast cancer patients with vascular invasion].Zhonghua Zhong Liu Za Zhi. 2007 Feb;29(2):137-40. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17645853 Chinese.
-
[Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].Zhonghua Zhong Liu Za Zhi. 2008 Dec;30(12):917-20. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173993 Chinese.
-
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.BMC Cancer. 2007 Apr 12;7:63. doi: 10.1186/1471-2407-7-63. BMC Cancer. 2007. PMID: 17430582 Free PMC article.
-
[Recent prognostic factors for breast cancer].Gan To Kagaku Ryoho. 1997 Apr;24(6):635-43. Gan To Kagaku Ryoho. 1997. PMID: 9126298 Review. Japanese.
-
Molecular prognostic factors for breast cancer metastasis and survival.Semin Radiat Oncol. 2002 Oct;12(4):319-28. doi: 10.1053/srao.2002.35251. Semin Radiat Oncol. 2002. PMID: 12382190 Review.
Cited by
-
Correlation Between Clinical-Pathologic Factors and Long-Term Follow-Up in Young Breast Cancer Patients.Transl Oncol. 2015 Aug;8(4):265-72. doi: 10.1016/j.tranon.2015.05.001. Transl Oncol. 2015. PMID: 26310372 Free PMC article.
-
Conversion of immunohistochemical markers and breast density are associated with pathological response and prognosis in very young breast cancer patients who fail to achieve a pathological complete response after neoadjuvant chemotherapy.Cancer Manag Res. 2019 Jun 20;11:5677-5690. doi: 10.2147/CMAR.S198844. eCollection 2019. Cancer Manag Res. 2019. PMID: 31417311 Free PMC article.
-
A retrospective comparative study of clinicopathological features between young and elderly women with breast cancer.Int J Clin Exp Med. 2015 Apr 15;8(4):5869-75. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26131178 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous